Jyong Biotech Ltd. Successfully Raises $20 Million From Nasdaq IPO to Enter $11.9 Billion Urology Health Market

Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).

Proyek rantai industri sumber daya nikel dan baterai Indonesia yang melibatkan perusahaan China menggelar upacara peletakan batu pertama

Quantum X Announces Major Quantum Computing Breakthrough, Set to Surpass GPUs in Financial Applications

How close was Iran to making a nuclear bomb and what's really going on with Israel's nuclear program?

As the world reels from what Trump has dubbed the '12-day war' between Israel and Iran, we are faced with more questions than answers.

A Date with Light and Shadow Across Thousands of Miles: Beijing International Film Festival Shines in Sydney